An Unusual Presentation of COVID-19: Hemorrhagic Pericardial Effusion With Tamponade PhysiologyCardiology Published on 2021-02-192022-10-31 Journal: Cureus [Category] COVID-19, [키워드] Cardiac tamponade chest pain Colchicine coronavirus disease COVID covid and heart covid pericarditis COVID-19 deficiency diagnosed echocardiographic effusion Hemorrhagic hemorrhagic pericardial effusion hemorrhagic pericarditis Leiden Local MRI mri cardiac pericardial effusion Physiology presentation Pulmonary emboli Symptoms tamponade treated viral pericarditis [DOI] 10.7759/cureus.13438 PMC 바로가기 [Article Type] Cardiology
The Rheumatology Drugs for COVID-19 Management: Which and When?Review Published on 2021-02-162022-10-30 Journal: Journal of Clinical Medicine [Category] COVID-19, [키워드] absence anti-IL-1 anti-IL-6 anti-IL-6 drugs anti-TNF antiviral therapy approach approved Baricitinib characterized Clinical management Clinical outcome Cochrane Library Colchicine Complication concerning Corticosteroids COVID-19 database drug hallmark HCQ heterogeneity hyperinflammatory status IL-2 IL-6 IL-7 IL-8 immunoglobulins immunomodulatory drug intravenous Necrosis neutralize patients patients with COVID-19 Pneumonia Result rheumatic disease SARS-CoV2 searched severe COVID-19 patients therapeutic strategy Treatment Vaccine while [DOI] 10.3390/jcm10040783 PMC 바로가기 [Article Type] Review
COVID-19 in Autoinflammatory Diseases with Immunosuppressive TreatmentArticle Published on 2021-02-052022-10-30 Journal: Journal of Clinical Medicine [Category] COVID-19, [키워드] acute COVID-19 autoinflammatory disease Autoinflammatory diseases CAPS case sery Colchicine Combination coronavirus Course COVID-19 COVID-19 disease COVID-19 in patient disease effective expand FIVE FMF Follow-up heterozygous homozygous immunosuppressive increase interleukin-1 Mediterranean fever MEFV methotrexate Mild NLRP3 Patient patients Periodic positive antibody response risk SARS-CoV-2 SARS-CoV-2 antibody response SARS-CoV-2 immunity therapy treated [DOI] 10.3390/jcm10040605 PMC 바로가기 [Article Type] Article
Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial중등도에서 중증 COVID-19에 대한 콜히친의 유익한 효과: 무작위, 이중 맹검, 위약 대조 임상 시험Randomized Controlled Trial Published on 2021-02-042022-08-13 Journal: RMD Open [Category] MERS, 임상, [키워드] 1:1 addition Admission Colchicine colchicine group COVID-19 death death rate diarrhoea died double-blinded drug Effect evaluate groups hospitalisation intensive care IQR log moderate moderate to severe Mortality objective outcome assessment outcomes oxygen Oxygen therapy Patient Placebo placebo group placebo-controlled clinical trial primary endpoint primary endpoints randomised reduced regimen registration number Result Safe severe COVID-19 standard treatment supplemental oxygen Supplemental oxygen therapy the placebo group Treatment Two patient two patients [DOI] 10.1136/rmdopen-2020-001455 PMC 바로가기 [Article Type] Randomized Controlled Trial
Characteristics of clinical trials evaluating cardiovascular therapies for Coronavirus Disease 2019 Registered on ClinicalTrials.gov: a cross sectional analysisClinicalTrials.gov에 등록된 코로나바이러스 질병 2019에 대한 심혈관 요법을 평가하는 임상 시험의 특성: 횡단면 분석Article Published on 2021-02-012022-09-11 Journal: American heart journal [Category] SARS, 임상, [키워드] (defibrotide) aldosterone Analysis angiotensin Anti-inflammatory categories category Characteristics clinical care clinical trial clinical trials ClinicalTrials Cohort Colchicine Combination Complete Composite convalescent plasma COVID-19 COVID-19 treatment cross database defibrotide described disease drugs Enrollment Europe European evaluate evaluated Evidence extracorporeal membrane oxygenation Final followed by Generalizability Health Health policy implementation Inpatients lead less majority morbidity Mortality MOST network North North America outcomes participant Patient patients hospitalized plan platform Primary outcome protocol Randomized Registered Renin risk single center Sponsor study population therapeutic Therapies therapy Treatment trials were excluded with COVID-19 [DOI] 10.1016/j.ahj.2020.10.065 PMC 바로가기 [Article Type] Article
Systematic Review of COVID-19 Related Myocarditis: Insights on Management and OutcomeCOVID-19 관련 심근염의 체계적인 검토: 관리 및 결과에 대한 통찰력Article Published on 2021-02-012022-09-12 Journal: Cardiovascular revascularization medicine : includ [Category] MERS, 진단, [키워드] acute respiratory syndrome age appear article asymptomatic infection Cochrane Library Colchicine Combination conducted coronavirus COVID-19 COVID-19 infection database death debatable described Diagnosis diagnosis of COVID-19 discharge echocardiography electrocardiogram elevated endotracheal English language glucocorticoid Glucocorticoids Google Scholar guideline hypertension IL-6 inhibitors Infection insight intubation knowledge Like majority male management manifestation multi-organ failure myocarditis outcome OVID pandemic past medical history Patient prevalent reduced reported review SARS-CoV-2 steroid survived the median therapy Tocilizumab treated Treatment treatment approach viral illnesses was performed with COVID-19 World Health Organization [DOI] 10.1016/j.carrev.2020.08.028 PMC 바로가기 [Article Type] Article
A Rare Case of Acute Pericarditis Due to SARS-CoV-2 Managed With Aspirin and ColchicineCardiology Published on 2021-01-062022-10-31 Journal: Cureus [Category] COVID-19, [키워드] Acute pericarditis Arthritis Aspirin Chest Colchicine cough COVID 19 COVID-19 pneumonia debatable Ejection fraction elevated FIVE High dose hypertension Infection Injury myocarditis Nasopharyngeal swab nonsteroidal anti-inflammatory drug NSAIDS oxygen saturation Patient patients with SARS-CoV-2 Pericarditis positive predominant reported rising SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 RNA Shortness of breath treated ventricular viral pericarditis [DOI] 10.7759/cureus.12534 PMC 바로가기 [Article Type] Cardiology
Treatment of severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and coronavirus disease 2019 (COVID-19): a systematic review of in vitro , in vivo , and clinical trials중증급성호흡기증후군(SARS), 중동호흡기증후군(MERS), 코로나바이러스 감염증 2019(COVID-19)의 치료: 시험관 내, 생체 내 및 임상 시험에 대한 체계적인 검토Review Published on 2021-01-012022-09-10 Journal: Theranostics [Category] MERS, 비임상, 신약개발, 임상, 치료제, [키워드] acute respiratory syndrome article breath Clinical studies clinical study clinical trial Colchicine conducted controlled trials Convalescent plasma therapy coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 daclatasvir disease effective eight English Evidence help highlight identify in vitro In vitro studies in vivo information investigated MERS Meta-analysis Middle East Middle East respiratory syndrome Mortality Other outcome participant patients positive provide Randomized controlled trial rationale RCT RCTs Remdesivir required Research respiratory SARS Screening searched Severe acute respiratory syndrome sofosbuvir sofosbuvir/daclatasvir Spread syndrome systematic review therapeutic therapeutic agent therapeutic agents therapeutic effect therapy treating COVID-19 Treatment [DOI] 10.7150/thno.48342 PMC 바로가기 [Article Type] Review
Treatment considerations for Behçet disease in the era of COVID-19: A narrative reviewReview Published on 2021-01-012023-07-12 Journal: Dermatologic therapy [Category] SARS, [키워드] Behçet syndrome Colchicine COVID-19 SARS-CoV-2 [DOI] 10.1111/dth.14507 [Article Type] Review
A systematic review of the infectious complications of colchicine and the use of colchicine to treat infectionsArticle Published on 2020-12-172023-07-02 Journal: Seminars in arthritis and rheumatism [Category] SARS, [키워드] adverse event Colchicine COVID-19 Infection Infectious disease SARS-CoV-2 [DOI] 10.1016/j.semarthrit.2020.11.007 PMC 바로가기 [Article Type] Article